CN Patent

CN107773561A — 一种甲磺酸洛美他派胶囊及其制备方法

Assigned to Tianjin Hankang Pharmaceutical Biotechnology Co Ltd · Expires 2018-03-09 · 8y expired

What this patent protects

本发明涉及一种甲磺酸洛美他派胶囊及其制备方法。本发明的甲磺酸洛美他派胶囊，包含活性成分甲磺酸洛美他派和作为崩解剂和粘合剂的羟丙纤维素。本发明不仅可以迅速崩解和快速溶出，且工艺简单、质量稳定。

USPTO Abstract

本发明涉及一种甲磺酸洛美他派胶囊及其制备方法。本发明的甲磺酸洛美他派胶囊，包含活性成分甲磺酸洛美他派和作为崩解剂和粘合剂的羟丙纤维素。本发明不仅可以迅速崩解和快速溶出，且工艺简单、质量稳定。

Drugs covered by this patent

Patent Metadata

Patent number
CN107773561A
Jurisdiction
CN
Classification
—
Expires
2018-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Hankang Pharmaceutical Biotechnology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.